Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

Home
/
update
/
details

ICGA Launches India's First Open-Access Cancer Data Portal to Advance Personalized Treatment

NextEdge Admin

22 Sep 2024

2 min 16 sec

The Indian Cancer Genome Atlas (ICGA) has launched a groundbreaking cancer data portal, providing open access to crucial information from Indian cancer patients. This resource is designed to support researchers and clinicians in developing personalized treatment strategies tailored to India's unique population. Initially, the platform includes data from 50 breast cancer patients, with plans to expand to over 500 within a year.

Operated by the ICGA Foundation, a not-for-profit organization, this initiative is supported by over 50 clinicians, researchers, and data analysts, aligning with India’s PRIDE guidelines that promote ethical collaboration in cancer research. Historically, cancer treatments in India have relied on Western data, which may not account for the molecular differences in Indian patients. The ICGA’s mission is to create India-specific datasets, facilitating the development of personalized therapies.

The portal is India's first to provide comprehensive multi-omics data, encompassing DNA, RNA, and protein profiles integrated with clinical outcomes. Experts like Professor Shekhar C Mande from Savitribai Phule Pune University highlight the portal’s potential to accelerate scientific discoveries and improve patient outcomes.

Global leaders, including Dr JC Zenklusen of The Cancer Genome Atlas (USA) and Professor Sunil Badve of Georgia University, urge others to contribute to this initiative. Dr Anand Deshpande, Non-Executive Director at ICGA, emphasized the importance of tailoring treatments to India’s genetic and environmental factors, calling for collective efforts to combat cancer through this revolutionary platform.